Top-News
Gesundheitswesen: Ausstattung u. Produkte Deutschland

Carl Zeiss Meditec AG ADR News

Aktie
WKN:  A0YGQ7 ISIN:  US14218T1051 US-Symbol:  CZMWY
94,00 €
+0,00 €
0,00%
21.05.24 17:50:15
Handeln Depot/Watchlist
Aktienanzahl *
89,44 Mio.
Marktkapitalisierung *
8,52 Mrd. €
Streubesitz
-
Faktor
1
Originalaktie
DE0005313704
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 09.01.2024

Carl Zeiss Meditec AG ADR News

04.04.24 - PR Newswire
Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market
Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market PR Newswire
04.04.24 - PR Newswire
Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market
Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market PR Newswire
28.03.24 - PR Newswire
ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024
ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024 PR Newswire
28.03.24 - PR Newswire
ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024
ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024 PR Newswire
11.01.24 - PR Newswire
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS PR Newswire
11.01.24 - PR Newswire
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS PR Newswire
15.12.23 - PR Newswire
Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.) PR Newswire
23.10.18 - PR Newswire
Carl Zeiss Meditec to Acquire IanTECH, Inc. to expand its portfolio in cataract surgery
Carl Zeiss Meditec to Acquire IanTECH, Inc. to expand its portfolio in cataract surgery PR Newswire
05.10.18 - PR Newswire
ZEISS Receives FDA Approval for ReLEx SMILE, Expanding Myopia Treatment to Patients with Astigmatism
ZEISS Receives FDA Approval for ReLEx SMILE, Expanding Myopia Treatment to Patients with Astigmatism Small Incision Lenticule Extraction, better known as ReLEx SMILE from ...
21.09.18 - PR Newswire
ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide
ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide PR Newswire
21.09.18 - PR Newswire
ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide
ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide ZEISS announces two new milestones in refractive technology, with 1.5 million ...
21.09.18 - PR Newswire
ZEISS Presents Integrated Data-Driven Digital Solutions at ESCRS, Advancing Eye Care for Patients Every Step of the Way
ZEISS Presents Integrated Data-​Driven Digital Solutions at ESCRS, Advancing Eye Care for Patients Every Step of the Way PR Newswire
21.09.18 - PR Newswire
ZEISS Presents Integrated Data-Driven Digital Solutions at ESCRS, Advancing Eye Care for Patients Every Step of the Way
ZEISS Presents Integrated Data-​Driven Digital Solutions at ESCRS, Advancing Eye Care for Patients Every Step of the Way PR Newswire
04.11.15 - PR Newswire
ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery
ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery PR Newswire
04.11.15 - PR Newswire
ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery
ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery PR Newswire
02.12.13 - PR Newswire
New Breast Cancer Study Results Published in The Lancet Compare Targeted Radiotherapy During Surgery With ZEISS INTRABEAM to Traditional Post-Surgical Radiotherapy Treatment
New Breast Cancer Study Results Published in The Lancet Compare Targeted Radiotherapy During Surgery With ZEISS INTRABEAM to Traditional Post-​Surgical Radiotherapy ...

Newssuche

Videos

newspaper
17.05.24 -6,64%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »